Apollomics Inc. Class A Ordinary Shares Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
USD 21.50
(+430.86%)
Based on the Apollomics Inc. Class A Ordinary Shares stock forecast from 2 analysts, the average analyst target price for Apollomics Inc. Class A Ordinary Shares is USD 21.50 over the next 12 months. Apollomics Inc. Class A Ordinary Shares’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Apollomics Inc. Class A Ordinary Shares is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, Apollomics Inc. Class A Ordinary Shares’s stock price was USD 4.05. Apollomics Inc. Class A Ordinary Shares’s stock price has changed by -5.59% over the past week, -20.43% over the past month and 0% over the last year.
No recent analyst target price found for Apollomics Inc. Class A Ordinary Shares
No recent average analyst rating found for Apollomics Inc. Class A Ordinary Shares
Company Overview
Apollomics, Inc., a biotechnology company, engages in the discovery and development of oncology therapies to address unmet medical needs in California, Hangzhou, Shanghai, China, and Australia. It develops APL-101 (Vebreltinib), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors; APL-102 is an oral active, small molecule multiple tyrosine kinase inhibitor for liver cancer, breast cancer, and esophageal cancer; and APL-122, a tumor inhibitor candidate to treat cancers within the brain. The company was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2015 and is based in Foster City, California. Address: Read Less
Apollomics, Inc., a biotechnology company, engages in the discovery and development of oncology therapies to address unmet medical needs in California, Hangzhou, Shanghai, China, and Australia. It develops APL-101 (Vebreltinib), a potent, selective c-Met inhibitor for the treatme...Read More
N/A
N/A
43
N/A
USD
USA
Adjusted Closing Price
Loading...
Technical Indicators
Unadjusted Closing Price
Loading...
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Share Volume
Loading...
Relative Performance
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Stocks Similar To Apollomics Inc. Class A Ordinary Shares (Sector: Biotechnology )
Based on ratings from 2 analysts Apollomics Inc. Class A Ordinary Shares's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and hold ratings.
Unfortunately we do not have enough data on APLM's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for APLM is USD 21.50 over the next 12 months. The maximum analyst target price is USD 25 while the minimum anlayst target price is USD 18.
Unfortunately we do not have enough data on APLM's stock to indicate if its overvalued.
The last closing price of APLM's stock was USD 4.05.
Unfortunately we do not currently have any market capitalization data for APLM's stock.
Based on targets from 2 analysts, the average taret price for APLM is projected at USD 21.50 over the next 12 months.
This means that APLM's stock price may go up by +430.86% over the next 12 months.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
There is nothing we particularly dislike
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for APLM !
Please login to proceed
Sorry - extended search is only available for registered users.
